IGF2BP1, a New Target to Overcome Drug Resistance in Melanoma?

IGF2BP1, a New Target to Overcome Drug Resistance in Melanoma?

Saved in:
Bibliographic Details
Published in:Frontiers in pharmacology Vol. 13; p. 947363
Main Authors: Xi, Yufeng, Wang, Yujia
Format: Journal Article
Language:English
Published: Frontiers Media S.A 22-07-2022
Subjects:
drug resistance
IGF2BP1
melanoma
mRNA stabilization
Pharmacology
RNA binding protein
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
This article was submitted to Pharmacology of Anti-Cancer Drugs, a section of the journal Frontiers in Pharmacology
Edited by: Vladimir Spiegelman, Penn State Milton S. Hershey Medical Center, United States
Reviewed by: Nadine Bley, University of Halle, Germany
ISSN:1663-9812
1663-9812
DOI:10.3389/fphar.2022.947363